Cemiplimab
ATC L01FF06 · 9 markets · 14 records
AU 3 records · 3 strengths
- 350 mg/7 mLinjectionLIBTAYO
- 350 mginjectionLIBTAYO cemiplimab 350 mg concentrate for solution for infusion
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 2 records · 2 strengths
- 350 mg/7 mLinjectionManufacturer: Catalent Indiana, LLC
- 50 mginjectionLIBTAYO
GB 1 records · 1 strengths
- 350 mg/7 mLinjectionLibtayo 350mg/7ml concentrate for solution for infusion vials
CA 1 records · 1 strengths
- 50 mg/1 mLliquidLIBTAYO
ES 1 records · 1 strengths
- 50 mg/1 mLinjectionLIBTAYO
MX 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
TW 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 strengths
- 350 mg/7 mLinjectionLIBTAYO 350 mg, solution à diluer pour perfusion
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.